Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Citi boosts its Intel price target to $130, arguing a new CPU TAM framework driven by agentic AI workloads positions ...
Marvell Technology extended a dramatic rally, up 45% in a month on record revenue, while investors weigh whether to t...
When tariffs go away and a new housing bill takes shape, the real estate world could see big changes in loans, rates,...
Mondelez stock inches toward a golden cross as easing cocoa prices and stronger emerging-market demand rally the snac...
Cisco is deploying personalized AI agents to its 90,000 employees this fiscal year, promising faster decisions and sm...
A new government seed money option could jumpstart your child’s education savings. This guide explains eligibility, h...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
June brought a notable move in the tech pocket as D-Wave Quantum jumped after a price-target boost from Mizuho. This ...
Micron stock surged last month on AI memory demand and strong results, then faced a July pullback as traders reassess...
Is a $500,000 nest egg enough to retire? This guide breaks down real-world scenarios, withdrawal strategies, and inco...
The Oct. 7 attacks set off a long-term shift in the Middle East that investors are still pricing in. This oct. attack...